Save the date: CHILI returns on October 29, 2021!
CHILI – the Conference on Hybrid Imaging Live – will return with its engaging format on October 29, 2021. A full day of hybrid imaging awaits you with a clear focus how hybrid imaging can guide clinical therapy in a multitude of clinical applications in oncology, infection and inflammation. It will again be streamed online only and will be free of charge for everyone.
A professional studio, live moderation and live speakers will make CHILI stand out from other online conferences with pre-recorded talks from the can. CHILI is live, CHILI is fresh, CHILI is spicy.
Date: October 29, 2021
Time: 08:30-18:00 (CET)
Location: Online only
Credits: A request for 7 CME credits was made.
Registration: FREE (opens soon)
The four sessions of CHILI will cover various aspects relating to the fusion of radiology and nuclear medicine with a special focus on its clinical application and therapy management. The first three sessions are dedicated to exploring ways to guide clinical therapy with the use of hybrid imaging in the fields of oncology, infection and inflammation. Each of the lectures will be followed by a discussion and Q&A with the audience.
The conference will conclude with a session dedicated to new developments that are on the horizon for hybrid imaging, such as the great leap for full body PET/CT, how to evolve clinical applications for artificial intelligence in multimodality hybrid imaging as well as the translational potential of novel molecular imaging probes.
Please note that the programme is still subject to change.
08:25-10:15
Session 1
Oncology 1: Hybrid imaging as the standard of care
show details +
08:25-08:30 – Introduction to CHILI 4.0 (Clemens Cyran)
08:30-08:50
PET/CT in lymphoma – the standard of clinical care
tba
08:50-09:10
Lung carcinoma – the challenges in staging and therapy monitoring
tba
09:10-09:30
Why PET/CT in HNSCC?
tba
09:10-09:30
Melanoma: imaging-based therapeutic management
tba
09:50-10:15
Q&A with the experts
10:30-12:15
Session 2
Oncology 2: The world beyond FDG
show details +
10:30-10:50
Neuroendocrine tumors: therapeutic magagement with SSR-targeting tracers
Clemens Cyran, Munich /DE
10:50-11:10
Prostate carcinoma: PSMA PET/CT in clinical decision guidance
tba
11:10-11:30
FAPI PET: the new FDG in solid tumors?
tba
11:30-11:50
FET PET/MRI in neuro-oncology
tba
11:50-12:15
Discussion and Q&A with the experts
12:30-13:15
Special session
Sponsored symposium & discussion
More info will follow soon.
13:30-15:15
Session 3
Infection and Inflammation
show details +
13:30-13:50
Rheumatological diseases: the role of hybrid imaging
tba
13:50-14:10
Prothesis infection – from aortic replacements to endoprothesis
Michel Eisenblätter, Freiburg /DE
14:10-14:30
Specific tracers in imaging of inflammation
José Vercher-Conejero, Barcelona /ES
14:30-14:50
Hybrid imaging in COVID-19: What have we learned?
tba
14:50-15:15
Discussion and Q&A with the experts
15:30-16:00
Special session
Sponsored symposium & discussion
More info will follow soon.
16:15-18:00
Session 4
New Horizons for Hybrid Imaging
show details +
16:15-16:40
Total body PET/CT – key benefits and applications
Thomas Beyer, Vienna /AT
16:40-17:05
AI in multimodality hybrid imaging
tba
17:05-17:30
Novel molecular imaging probes for oncologic imaging and what’s their translational potential
tba
17:30-18:00
Round table discussion:
The prospects of clinical implementation for new modalities, probes and algorithms on the horizon.